Board of Directors
Swiss (born 1964)
Chairman of the Board since 2010
Member of the ESG Task Force
Board Member since 2009
Other current activities:
Member of the Board of Julius Bär Gruppe AG (Nomination and Compensation Committee), Ypsomed Holding AG(Compensation Committee), Swiss Medtech Association, Basel Chamber of Commerce (HKBB), International Team for Implantology (ITI)1, Basel, Supervisory Board Member of IMD (Audit Committee Chair), Lausanne; Juror at VentureKick and Business Angel.
From 2002 to 2010, he was CEO of Straumann, which he joined as CFO in 1998. Later he served as Board member of Vifor Pharma; Chairman and Co-CEO of the Vitra Holding AG, a family-owned furniture and retail company; Chairman of the Siegfried AG, a listed pharma service company, and Vice Chairman of the Moser Group, a privately owned luxury watchmaking company. He started his professional life at UBS in Investment Banking in 1988.
Executive MBA from IMD; Bachelor’s degree from the University of Applied Science (HWV) in St. Gallen.
Key attributes for the Board:
Key attributes for the Board: Mr Achermann represents continuity, stability and credibility among the various stakeholders. The Board benefits from his extensive knowledge of the dental industry as well as the deep experience and insight gained from directorships in other industries.
1 For relationship to Straumann see Note 9.4 on p. 169 of the Annual Report 2020.